BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34607910)

  • 1. mTOR-Activating Mutations in
    Schlingmann KP; Jouret F; Shen K; Nigam A; Arjona FJ; Dafinger C; Houillier P; Jones DP; Kleinerüschkamp F; Oh J; Godefroid N; Eltan M; Güran T; Burtey S; Parotte MC; König J; Braun A; Bos C; Ibars Serra M; Rehmann H; Zwartkruis FJT; Renkema KY; Klingel K; Schulze-Bahr E; Schermer B; Bergmann C; Altmüller J; Thiele H; Beck BB; Dahan K; Sabatini D; Liebau MC; Vargas-Poussou R; Knoers NVAM; Konrad M; de Baaij JHF
    J Am Soc Nephrol; 2021 Nov; 32(11):2885-2899. PubMed ID: 34607910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.
    Deeb A; Abood SA; Simon J; Dastoor H; Pearce SH; Sayer JA
    BMC Res Notes; 2013 Dec; 6():527. PubMed ID: 24321194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic causes of hypomagnesemia, a clinical overview.
    Viering DHHM; de Baaij JHF; Walsh SB; Kleta R; Bockenhauer D
    Pediatr Nephrol; 2017 Jul; 32(7):1123-1135. PubMed ID: 27234911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.
    Ferrè S; de Baaij JH; Ferreira P; Germann R; de Klerk JB; Lavrijsen M; van Zeeland F; Venselaar H; Kluijtmans LA; Hoenderop JG; Bindels RJ
    J Am Soc Nephrol; 2014 Mar; 25(3):574-86. PubMed ID: 24204001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel
    Zhang H; Ling C; Liu X
    Clin Nephrol; 2019 Aug; 92(2):95-97. PubMed ID: 31232269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: report of three Turkish siblings.
    Peru H; Akin F; Elmas S; Elmaci AM; Konrad M
    Pediatr Nephrol; 2008 Jun; 23(6):1009-12. PubMed ID: 18253757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated Cardiomyopathy With Concomitant Salt-Losing Renal Tubulopathy Caused by Heterozygous
    de Frutos F; Diez-Lopez C; García-Romero E; Gondra L; Madariaga L; Ariceta G; García-Castaño A; Melilli E; Herrador L; Triguero-Llonch L; Gran F; Rosenfeld L; Llatjos R; Comin-Colet J; González-Costello J
    Circ Genom Precis Med; 2024 Apr; 17(2):e004336. PubMed ID: 38372174
    [No Abstract]   [Full Text] [Related]  

  • 8. Mg2+ homeostasis: the balancing act of TRPM6.
    van der Wijst J; Bindels RJ; Hoenderop JG
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):361-9. PubMed ID: 24906182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited disorders of renal hypomagnesaemia.
    Konrad M; Schlingmann KP
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv63-71. PubMed ID: 25165187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation of the claudin 16 gene in familial hypomagnesemia with hypercalciuria and nephrocalcinosis mimicking rickets.
    Kasapkara CS; Tumer L; Okur I; Hasanoglu A
    Genet Couns; 2011; 22(2):187-92. PubMed ID: 21848011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family.
    Al-Haggar M; Bakr A; Tajima T; Fujieda K; Hammad A; Soliman O; Darwish A; Al-Said A; Yahia S; Abdel-Hady D
    Clin Exp Nephrol; 2009 Aug; 13(4):288-294. PubMed ID: 19165416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations.
    Perdomo-Ramirez A; de Armas-Ortiz M; Ramos-Trujillo E; Suarez-Artiles L; Claverie-Martin F
    BMC Med Genet; 2019 Jan; 20(1):6. PubMed ID: 30621608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Perdomo-Ramirez A; Aguirre M; Davitaia T; Ariceta G; Ramos-Trujillo E; ; Claverie-Martin F
    Gene; 2019 Mar; 689():227-234. PubMed ID: 30576809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.
    Long PA; Zimmermann MT; Kim M; Evans JM; Xu X; Olson TM
    Hum Genet; 2016 Aug; 135(8):909-917. PubMed ID: 27234373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal diseases that course with hypomagnesemia. Comments on a new hereditary hypomagnesemic tubulopathy.
    Garcia-Nieto VM; Claverie-Martin F; Moraleda-Mesa T; Perdomo-Ramírez A; Fraga-Rodríguez GM; Luis-Yanes MI; Ramos-Trujillo E;
    Nefrologia (Engl Ed); 2024; 44(1):23-31. PubMed ID: 38350738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of Turkish patients with familial hypomagnesaemia: novel mutations in TRPM6 and CLDN16 genes.
    Guran T; Akcay T; Bereket A; Atay Z; Turan S; Haisch L; Konrad M; Schlingmann KP
    Nephrol Dial Transplant; 2012 Feb; 27(2):667-73. PubMed ID: 21669885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.
    Oshiro N; Rapley J; Avruch J
    J Biol Chem; 2014 Jan; 289(5):2658-74. PubMed ID: 24337580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.
    de Baaij JH; Dorresteijn EM; Hennekam EA; Kamsteeg EJ; Meijer R; Dahan K; Muller M; van den Dorpel MA; Bindels RJ; Hoenderop JG; Devuyst O; Knoers NV
    Nephrol Dial Transplant; 2015 Jun; 30(6):952-7. PubMed ID: 25765846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagC
    Kim M; Lu L; Dvornikov AV; Ma X; Ding Y; Zhu P; Olson TM; Lin X; Xu X
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.
    Godron A; Harambat J; Boccio V; Mensire A; May A; Rigothier C; Couzi L; Barrou B; Godin M; Chauveau D; Faguer S; Vallet M; Cochat P; Eckart P; Guest G; Guigonis V; Houillier P; Blanchard A; Jeunemaitre X; Vargas-Poussou R
    Clin J Am Soc Nephrol; 2012 May; 7(5):801-9. PubMed ID: 22422540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.